After confirming the positive expression of BAFF‐R on three CLL cell lines, we assessed the antigen‐specific cytotoxicity of our BAFF‐R CAR T cells using CD107a degranulation and cytokine release assays. The gene discussed is TNFRSF13C; the disease is B-cell chronic lymphocytic leukemia.